FATE
USDFate Therapeutics Inc. Common Stock
$1.190-0.030 (-2.459%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.220
High
$1.300
Low
$1.185
Volume
3.02M
Company Fundamentals
Market Cap
137.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $0.66Current $1.190High $3.5
Related News
Analyst Upgrades
HC Wainwright & Co. Upgrades Fate Therapeutics to Buy, Maintains Price Target to $5
HC Wainwright & Co. analyst Robert Burns upgrades Fate Therapeutics from Neutral to Buy and maintains the price target from $5 to $5.
View more
Related Stocks
EQC
Equity Commonwealth Common Shares of Beneficial Interest
NASDAQ
Real Estate Inv...
HROWL
Harrow Inc. 8.625% Senior Notes due 2026
NASDAQ
Biotechnology: ...
XPO
XPO Inc.
NASDAQ
Transportation ...
ADXN
Addex Therapeutics Ltd American Depositary Shares
NASDAQ
Biotechnology: ...
VTYX
Ventyx Biosciences Inc.
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.